Hap Trading, LLC Oncternal Therapeutics, Inc. Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Oncternal Therapeutics, Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 10,700 shares of ONCT stock, worth $5,671. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,700Holding current value
$5,671% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ONCT
# of Institutions
3Shares Held
362KCall Options Held
0Put Options Held
0About Oncternal Therapeutics, Inc.
- Ticker ONCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,517,200
- Market Cap $29.4M
- Description
- Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...